Sat - Sun: Closed
Title Image

Merz Therapeutics GmbH Together with Pyridam Farma Presents Innovative Products for the Indonesian Community

Merz Therapeutics GmbH Together with Pyridam Farma Presents Innovative Products for the Indonesian Community

Jakarta, 22 March 2022 – Merz Therapeutics GmbH, an affiliate of Merz Pharmaceutical GmbH which excels in neurotoxin field with Pyridam Farma as one of the public Healthcare companies in Indonesia, announced that together they will launch an innovator product for the Indonesian market.

Innovator’s product is indicated for the treatment of patients with chronic liver disease (CLD), low liver detoxification ability, and other chronic conditions. Simultaneously, they also launched a botulinum neurotoxin product that focuses on neurological disorders such as cervical dystonia, blepharospasm, post-stroke spasticity, and hypersalivation. For dermatology products, they also have a variety of products to treat Alopecia, reduce hair loss, and promote natural hair growth.

Lee Yan Gwan as CEO of Pyridam Farma explained, “We are very pleased and proud to have a strategic partnership with one of the world’s leading healthcare companies with a long history of innovation. This collaboration will strengthen our product offerings to our customers to include innovative and high quality products from Merz Therapeutics such as Xeomin, Hepa Merz, Pantogar, and other products under development. This collaboration is also very much in line with the vision of Pyridam Farma and Merz Therapeutics, which is to create a healthier life and provide better results for the community.”

Pyridam Farma and Merz Therapeutics hope that this strategic collaboration can advance the Indonesian health industry, help Indonesians gain access to more innovative products, and obtain better health.

About Merz Therapeutics GmbH

Merz Therapeutics is one of Merz Pharmaceuticals GmbH’s businesses dedicated to improving the lives of patients worldwide. With a relentless research, development and culture of innovation, Merz Therapeutics strives to serve the unmet needs of patients and realize better outcomes. Merz Therapeutics seeks to address the unique needs of sufferers who suffer from movement disorders, neuronal disorders, liver disease, and other health conditions that greatly affect the patient’s quality of life.
Merz Therapeutics is headquartered in Frankfurt, Germany and represented in more than 90 countries, with North American affiliates based in Raleigh, North Carolina. Merz Pharmaceuticals GmbH is part of the Merz Group, a private, family-owned company that has dedicated more than 110 years to developing innovations that meet the needs of patients and customers.

About PT Pyridam Farma Tbk.

PT Pyridam Farma Tbk is a pharmaceutical company whose main business is the production and/or distribution of modern and traditional medicines and the distribution of medical devices such as laboratory equipment and PCR test kits. The company was founded in 1976 and has been a public company and has been listed on the Indonesia Stock Exchange since 2001.
PT Pyridam Farma Tbk. manufactures various kinds of pharmaceutical products ranging from antibiotics, vitamins, health supplements, to traditional medicines. The company has more than 200 products in the form of effervescent tablets, caplets, capsules, syrups, and creams.
PT Pyridam Farma Tbk also provides tolling services as well as MA Holder and has partnered with more than 10 global pharmaceutical companies to provide registration services along with product marketing.